Skip to main content

Peer Review reports

From: Combination of gemcitabine and docetaxel: a regimen overestimated in refractory metastatic osteosarcoma?

Original Submission
10 Jan 2018 Submitted Original manuscript
25 Feb 2018 Author responded Author comments - Jie Xu
Resubmission - Version 2
25 Feb 2018 Submitted Manuscript version 2
11 Mar 2018 Reviewed Reviewer Report - Manasi Mayekar
2 Apr 2018 Reviewed Reviewer Report - Valentina Chiadini
3 Apr 2018 Author responded Author comments - Jie Xu
Resubmission - Version 3
3 Apr 2018 Submitted Manuscript version 3
8 May 2018 Reviewed Reviewer Report - Giovanni Grignani
21 May 2018 Reviewed Reviewer Report - Tomohide Tsukahara
20 Jun 2018 Author responded Author comments - Jie Xu
Resubmission - Version 4
20 Jun 2018 Submitted Manuscript version 4
1 Jul 2018 Reviewed Reviewer Report - Giovanni Grignani
16 Jul 2018 Reviewed Reviewer Report - Reviewer 2
30 Jul 2018 Author responded Author comments - Jie Xu
Resubmission - Version 5
30 Jul 2018 Submitted Manuscript version 5
22 Sep 2018 Reviewed Reviewer Report - Giovanni Grignani
24 Sep 2018 Author responded Author comments - Jie Xu
Resubmission - Version 6
24 Sep 2018 Submitted Manuscript version 6
26 Sep 2018 Author responded Author comments - Jie Xu
Resubmission - Version 7
26 Sep 2018 Submitted Manuscript version 7
Publishing
28 Sep 2018 Editorially accepted
16 Oct 2018 Article published 10.1186/s12885-018-4872-x

You can find further information about peer review here.

Back to article page